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Abstract
Objective—To test whether overweight or obese employees who achieve clinically significant 
weight loss of 5% or greater have reduced medical expenditures, absenteeism, presenteeism, 
and/or improved Health-Related Quality Of Life (HRQOL).
Methods—The sample analyzed combines data from full-time overweight or obese employees 
who took part in one of the WAY to Health weight loss studies: one that took place in 17 
community colleges (935 employees) and another in 12 universities (933), all in North Carolina. 
The estimations are performed using non-linear difference-in-difference models where groups are 
identified by whether the employee achieved a 5% or greater weight loss (treated) or not (control) 
and the treatment variable indicates pre- and post-weight loss intervention. The outcomes analyzed 
are the average quarterly (90 days) amount of medical claims paid by the health insurer, number of 
days missed at work during the past month, Stanford Presenteeism Scale SPS-6 and the EQ-5D-3L 
measure of HRQOL.
Results—We find statistical evidence supporting that 5% or greater weight loss prevents 
deterioration in EQ-5D-3L scores by 0.026 points (p-value: 0.03) and reduces both absenteeism by 
0.258 days per month (p-value: 0.093) and the likelihood of showing low presenteeism (Stanford 
SPS-6 score between 7 and 9) by 2.9 percentage points (p-value: 0.083). No reduction in medical 
expenditures was observed.
Conclusions—Clinically significant weight loss among overweight or obese employees 
prevents short term deterioration in HRQOL and there is some evidence that employee 
productivity is increased. We find no evidence of a quick return on investment from reduced 
medical expenditures, although this may occur over longer periods.
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INTRODUCTION
Obesity rates in the United States have reached epidemic proportions, even among full time 
employees. Currently, over 28.5% of full time employees are obese (i.e. have a Body Mass 
Index or BMI greater than 30) and another 38% are overweight (i.e. have a BMI between 25 
and 30) (1). There are many health and economic costs associated with overweight and 
obesity in the workplace. This includes reduced Health Related Quality Of Life (HRQOL) 
among employees and higher incidence of chronic diseases (2–4), which translates into 
higher medical expenses (5), health insurance rates (6, 7), rates of absenteeism and 
presenteeism (8–10), and ultimately, reduced firm profitability.
This suggests that health and, depending on the cost of the intervention, firm profitability 
could be improved by successful efforts to reduce the prevalence of overweight and obesity 
in the workplace. Whereas some of these efforts have been successful at achieving weight 
loss or other health gains among employees (11, 12), there is limited evidence that these 
programs are cost saving (13). This may result because the few studies that addressed cost 
implications were based on studies with only modest weight loss (13). To address this 
concern, Finkelstein and colleagues compared changes in medical expenditures and 
absenteeism among overweight full time employees at North Carolina Community Colleges 
who took part into a weight loss study (referred to as CDC-WAY throughout) stratified by 
degree of weight loss (14). The hypothesis tested was that those who lost 5% or more weight
—a weight loss level that has been shown to yield clinical health benefits (15) —regardless 
of which arm of the study they were in, would have lower medical expenses and less 
absenteeism upon study conclusion (and after 18 months for medical expenditures) than 
those who gained weight or lost less than 5% of baseline weight. The authors were unable to 
reject the null hypothesis of no difference in outcomes (medical expenses and absenteeism) 
between the two groups at follow-up. However, the samples analyzed were small (667 
individuals for absenteeism and 279 for medical expenditures) and less than 20% of the 
participants showed 5% or greater weight loss. Consequently, the study findings were 
associated with large confidence intervals, which reduced the chances of finding statistically 
significant differences between groups.
To address this concern, this analysis revisits and extends the original study by using, in 
addition to data from CDC-WAY, identical data from a similar weight loss study, NHLBI-
WAY, targeting faculty and staff in other North Carolina colleges and universities. In 
addition, NHLBI-WAY data also allows us to test whether those with greater than 5% 
weight loss showed greater improvements in HRQOL, which is a likely mediator of 
improvements in medical expenditure and absenteeism, and to extend the analysis by 
measuring the impact that weight loss has on presenteeism. The latter allows for a more 
comprehensive assessment of the effect that weight loss has on employee productivity. This 
analysis also employs nonlinear statistical models in an effort to improve the efficiency of 
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the estimates. Altogether, the larger sample size, improved methodology, and expansion to 
include HRQOL and presenteeism will provide a more rigorous test of whether or not 
programs that are successful at inducing clinically significant weight losses among 
employees can also yield short-term financial benefits to the employers who offer them. If 
we find short-term benefits, financing the cost of these programs could provide justification 
for employers to increase the availability of weight loss programs for employees.
METHODS
Study design
The first source of data, CDC-WAY, was a study conducted among overweight and obese 
employees at 17 community colleges in North Carolina. The study was designed to test the 
effectiveness of three 12 month long weight loss interventions: a low cost environmental 
change intervention, a web-based weight loss program and a web-based weight loss program 
plus financial incentives. Details of the recruitment strategy of the 935 participants and their 
demographics are described elsewhere (16).
The second study, NHLBI-WAY, was designed to rigorously test the independent and 
combined effects of a self-directed web-based weight loss intervention. Participants in the 
incentive arm were eligible for up to $150 in CDC-WAY and up to $160 at the 12 month 
weigh-in in NHLBI-WAY, where payments were based on percentage of baseline weight 
lost. NHLBI-WAY was conducted over 18 months among employees from 12 different 
North Carolina universities, historically black colleges, and community colleges. 
Recruitment methods of 933 participants and eligibility criteria were nearly identical to that 
used in the prior study. Therefore the two samples are expected to be highly comparable. In 
each study, those who consented to participate were asked to sign a second consent allowing 
access to their health insurance claims data from the North Carolina State Health Plan for 
Teachers and Employees. Survey data and measured height and weight were collected 
between August 2005 and November 2006 for CDC-WAY and from September 2008 
through June 2010 for NHLBI-WAY. The participants of both studies had height and weight 
measured by a trained research team member and completed questionnaires at baseline and 
at several measurement points, including a 12 month assessment which, for consistency, is 
the primary endpoint used in this analysis. The questionnaires captured basic demographic 
data, diet and exercise patterns, and notably the EQ-5D-3L (17) measure of health related 
quality of life (NHLBI Only), a one-item question on absenteeism, and the Stanford 
Presenteeism Scale SPS-6 (18).
Claims data were extended to include additional 1.5 and 1 years post-12 month weigh-in for 
CDC-WAY and NHLBI-WAY respectively, and data from the year preceding the start of 
both studies. To address privacy concerns during IRB review, individuals with any evidence 
of claims related to mental health, substance abuse, HIV/AIDS, other communicable 
diseases, or genetic testing were not included in the final claims data set. All other claims for 
covered services for all consenting participants were made available to the research team. 
Both studies were approved by the institutional review boards at the University of North 
Carolina at Chapel Hill, the Research Triangle Institute (CDC-WAY only), and at each 
participating institution.
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The EQ-5D-3L algorithm converts each participant’s responses to the 5 EQ-5D 3-level 
questions into a HRQOL score that ranges between 0 (death) and 1 (perfect health). Note 
that EQ-5D-3L scores were available for NHLBI-WAY participants only and that negative 
scores (for health states deemed worse than death) are not observed in our sample of 
working employees. Absenteeism was measured in both studies as the self-reported number 
of days missed from work due to illness or injury over the 30 days preceding the 
measurement points. The SPS-6 scores range from 6 for those who do not suffer from 
presenteeism, in the sense that they can concentrate on and perform their work despite being 
overweight, to 30 for those whose work is most adversely affected by their weight. For 
tractability, we created a 4-category scale of presenteeism by aggregating the SPS-6 scores 
as follow: 6 for no presenteeism (55% of the sample), 7 to 9 for low presenteeism (19%), 10 
to 15 for moderate presenteeism (16%), and 16 to 30 for high presenteeism (11%). Quarterly 
amounts of medical expenditures paid by the health insurer (net of claim reversals) were 
computed during the intervention, 12 months before, and 18 months beyond the 12 month 
measurement point for both studies. In the primary analysis of this study, inpatient expenses 
were not included in the totals due to their limited number and large variance. All 
expenditures were converted to Quarter 1 2010 prices by means of the medical component 
of the consumer price index (19).
Statistical Analysis
Following Finkelstein et al., the analyses rely on a difference-in-difference (20) 
identification strategy where changes in the dependent variables from baseline to follow-up 
(the first difference) are compared between those who did or did not show evidence of 5% 
or greater weight loss (the second difference). Individuals with missing weight loss at 
follow-up but whose medical claims or survey data were available were included in the 
analyses and assumed to have less than 5% weight loss using an intention-to-treat analytic 
strategy. Because the primary research question is independent of study arm, this allowed 
for pooling individuals from different study arms across the two studies. We merely need to 
know whether each participant was successful at achieving 5% or greater weight loss; how 
the weight loss was achieved is immaterial for assessing its impact on these outcomes.
To estimate the effect of 5% or greater weight loss, in each model we regress the dependent 
variable on a binary variable indicating 5% or greater weight loss (vs. not), a binary variable 
indicating the follow-up (vs. baseline) period, and an interaction between these two 
variables. We also include the following control variables: age, baseline BMI, and binary 
variables indicating gender, ethnicity, faculty members, the study, intervention arms, and 
whether the participant has any of the following comorbidities: diabetes, chronic dizziness, 
bone or joint problems, chest pains or a past stroke/heart attack. For the medical 
expenditures analysis, an additional binary variable is used to identify the quarters in the 1.5 
year post 12 month weigh-in and an interaction variable between this variable and the binary 
variable indicating 5% weight loss.
In order to both improve efficiency and avoid biases (21), we use nonlinear models for the 
above regressions. Note that with such models, the interaction term no longer represents the 
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difference-in-difference estimate of the treatment effect (22), but this effect can be estimated 
by computing differences in changes in predicted outcomes for each treatment group from 
baseline to follow-up and using the bootstrap method to test for significance in the 
difference of the changes. In what follows, we describe the nonlinear models used to explain 
HRQOL, absenteeism, presenteeism and medical expenditures.
The EQ-5D-3L measure of HRQOL, which takes values between 0 and 1 in our sample, is 
characterized by a large number of individuals (48% of the sample) reporting a score of 1, 
perfect health. To account for this and to ensure the predictions fall into the 0 to 1 range, we 
apply the two-part model used by Oberhofer and Pfaffermayr in a similar context (23). The 
first part of the model consists of a logit model that predicts whether the individual reports 
perfect health. The second part is a fractional response model (24) only estimated for those 
with less than perfect health. The estimates are then combined as follows to estimate 
predicted scores for each person:
E(EQ5D|X) = Prob(EQD5 = 1|X) + (1 − Prob(EQD5 = 1|X)* E(EQ5D|EQ5D < 1,X),
where the probability of perfect health is estimated with the logit model and the conditional 
expectation for those with less than perfect health is estimated with a fractional logit model; 
X is a vector of control variables.
The absenteeism variable is characterized by a large number of zero outcomes (79% of the 
sample), which we deal with by applying a hurdle model that can be viewed as a two-part 
model in the context of count data (25). The first part is a logit model explaining whether the 
individual has missed any work and the second part is a truncated negative binomial model 
explaining the number of days missed for those who missed at least one day. The two parts 
are combined in a similar way as above to compute expected days missed for each 
individual in the sample. As for the presenteeism model, after verifying that the assumption 
of proportional odds holds (26), we have estimated it via a single ordered logit regression.
Quarterly total healthcare claims data are characterized by a large number of individuals 
with zero dollar claims (on average 23.5% of the sample each quarter) and, for those who do 
have claims, the distribution of expenditures is highly right-skewed with a small number of 
very expensive claims. To account for this, we again employ a two-part regression model. 
The first part is a logit model explaining the probability of participants having a positive 
claim. The second part estimates medical expenditures conditional on having positive 
expenditures using a GLM with logarithmic link and a Gamma distribution to account for 
the skewness of the expenditure distribution (27). Note that the link and distribution have 
been chosen using the Box-Cox (28) and Park (29, 30) tests. Results are then combined to 
compute expected expenditures for each individual in each period. In order to increase the 
efficiency of all estimations, we fit Generalized Estimating Equation (GEE) population-
averaged panel data models that account for correlations at individual level (31). All 
estimations were performed using Stata 11 and inference performed by means of a 
nonparametric bootstrap with 1,000 repetitions.
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Table 1 presents the combined study samples for the analysis of HRQOL, absenteeism, 
presenteeism and health expenditures. The CDC-WAY study enrolled 935 eligible 
participants and NHLBI-WAY enrolled 933, amounting to a combined baseline sample of 
1,868 participants. HRQOL and presenteeism come from NHLBI-WAY only. After 12 
months, 631 (67% of baseline) participants provided information on HRQOL. There were 
no statistically significant differences in baseline characteristics between respondents and 
non-respondents. Among all HRQOL respondents, 105 (17%) lost over 5% of their baseline 
weight over the 12 month follow-up period. 1,137 participants (61% of enrollees at baseline) 
provided absenteeism data after 12 months. As for comparison of baseline characteristics 
between respondents and non-respondents (not reported in the table) we find that 
respondents were slightly younger on average (46.3 v 47.2, p=0.04) and a higher proportion 
was female (84.2% v 81.4%, p=0.03). Of this sample, 197 (17%) lost 5% or more of 
baseline weight. Finally, 1,409 participants (75% of enrollees at baseline) consented to allow 
access to their medical claims; of these, 365 (25%) were not provided due to the presence of 
at least one of the exclusionary diagnosis codes (listed in the table). A further 106 (11%) 
were not enrolled in the State Health Plan. This left an analysis sample of 938 for the 
medical claims analysis of which, 114 (12%) lost 5% or greater weight. Respondents were 
slightly older (47.3 v 45.4, p=0.001) and more were male (19.7% v 13.1%).
The top portion of Table 2 compares baseline demographics between those who did or did 
not lose 5% or greater weight for each analysis sample. There were no statistically 
significant differences in baseline characteristics for any of the four samples analyzed. The 
only exception is that the percentage of faculty members was slightly higher and age slightly 
lower among those who have successfully lost 5% or more weight in the absenteeism 
sample. The bottom portion of Table 2 compares differences in weight change and the 
outcome variables of interest. Those who lost 5% or greater weight averaged about 9% 
weight loss in each sample, or nearly 19 pounds. Those whose weight loss did not exceed 
this threshold gained about one pound on average over the one year period of study, 
revealing a roughly 20 pound difference in weight at 12 months. At baseline, those who 
went on to lose 5% or more weight had slightly better outcomes in all models. These 
differences are controlled for in the difference-in-difference analysis.
Table 3 presents predictions at baseline and follow-up and the difference-in-difference 
estimates for those who did or did not lose 5% or greater weight for each variable of interest 
with corresponding regressions results available in Appendix Table 1. Concerning HRQOL, 
those who lost 5% or more weight showed almost no change in EQ-5D-3L scores, whereas 
those who did not saw their score deteriorate. As a result, the difference-in-difference 
estimate is positive and statistically significant, with a positive difference in HRQOL score 
of 0.026 (p-value: 0.03) for those who lost 5% or more weight compared with those who did 
not. Absenteeism rates increased for both groups at follow-up. However, the difference-in-
difference estimate provides marginal statistical evidence at the 10% level (p-value: 0.093) 
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that weight loss resulted in a reduction in absenteeism of 0.26 days per month relative to 
those who did not lose 5% or more of baseline weight.
The table then outlines results from the presenteeism analyses. Results show a 6.3% greater 
probability of not having any presenteeism for those with 5% or greater weight loss and 
lower probabilities for greater levels of presenteeism. However, the only result that is 
marginally statistically significant (p-value: 0.083) is the reduction by 3 percentage points in 
the probability of showing low presenteeism.
The last three lines show predicted quarterly health expenditures for the pre-intervention, 
intervention and post-intervention periods. Comparing row 1 with row 2, we see that those 
who lost 5% or greater weight had significantly lower medical expenditures during the pre-
intervention period. This suggests that those who went on to lose 5% or more weight had a 
different medical profile than those who did not. Regardless, after controlling for these 
differences, the difference-in-difference estimates for the intervention and post-intervention 
periods are not statistically significant, suggesting that weight loss did not positively 
influence medical expenditures over this period relative to those who did not lose the 
weight.
DISCUSSION
This study builds off of a prior analysis that showed no statistically significant 
improvements in absenteeism or medical expenses as a result of clinically relevant weight 
loss (14). This study also extends the prior analysis by including estimates for presenteeism 
and HRQOL. Whereas we come to similar conclusions with respect to medical expenditures, 
we find some evidence, at the 10% level of statistical significance (p-value: 0.093), that 
absenteeism rates improved relative to those who did not lose 5% or greater weight. We also 
find some evidence that weight loss moves individuals toward lower levels of presenteeism, 
although results are only marginally significant for low presenteeism levels (SPS-6 scores 
between 7 and 9). Together, these results suggest that employee productivity could be 
improved when a 5% or greater weight loss is achieved.
The results also reveal that 5% weight loss or greater prevented HRQOL deterioration. This 
highly statistically significant result (p=0.03) is consistent with cross-sectional studies 
showing an inverse relationship between weight and HRQOL (32–34). Conservatively, 
assuming that deterioration in HRQOL is only prevented during the intervention period (1 
year), that like in our sample, 17% of the participants lose 5% or more weight, and 
excluding any potential savings in absenteeism or presenteeism, we can compute an upper 
bound for the cost of an intervention that generates these results. Using a threshold for cost-
effectiveness of $50,000 per QALY, an intervention with per capita costs of $221 or less 
would be cost-effective (50,000 × 0.026 × 0.17 = $221). This for instance exceeds the cost 
of the CDC-WAY web-based program and web-based plus financial incentives 
(forthcoming).
Although there was no evidence of savings in medical expenditures, this result is not 
unexpected. While there is clear evidence from the Diabetes Prevention Program and other 
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studies that weight loss among obese individuals improves diabetes outcomes and risks for 
numerous chronic conditions (35–39), it may be unreasonable to expect substantial 
improvements in medical expenditures in such a short period among a population of full 
time employees, as the adverse health consequences of excess weight are more severe 
among those in their 50’s and beyond.
As for the limitations of our study, it is based on a select sample of majority female, 
overweight/obese employees at colleges and universities in North Carolina who agreed to 
participate in the research study. Moreover, in response to IRB concerns, 26% of the eligible 
sample for the claims analysis was removed due to the presence of mental health problems 
and other conditions (see Table 1). Excluding these individuals from the analysis may have 
caused an underestimation of the effect of weight loss on medical expenditures given the 
high correlation between BMI and poor mental health (40). Another point is that both our 
measures for HRQOL and productivity losses are self-reported and might yield biased 
results if weight loss were to alter the employee’s perception of her own health and 
productivity. It should be noted that self-reported number of days missed at work is a 
common measure of absenteeism that has been shown to be reliable (41).
Despite these limitations, this study suggests that clinically significant weight loss among 
overweight employees prevents deterioration in HRQOL and provides some evidence that 
these improvements may lead to increases in employee productivity. However, over the 
period analyzed, medical expenditures did not appear to be affected. Future studies should 
attempt to gather objective data on these outcomes over an extended period, and include 
additional measures of employee output, such as job turnover, worker’s compensation costs, 
and other measures of productivity, in efforts to provide greater evidence on the long term 
economic benefits to employers of sustained weight loss. Research should also continue to 
identify strategies that are effective in generating and sustaining this level of weight loss 
among overweight employees so that long-term health and economic benefits are fully 
realized.
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Appendix
Table 1
Parameter estimates of the two-part models for HRQOL, absenteeism, presenteeism and 
health expenditures
HRQOL Absenteeism Presenteeism Health Expenditures†
Logit F-logit Logit ZTNB Ordered logit Logit Log-Gamma
GLM
5% weight loss 0.335 0.014 −0.382 0.019 −0.280 −0.330* −0.240
(0.221) (0.415) (0.216) (0.282) (0.200) (0.161) (0.173)
Intervention dummy −0.422*** −0.056 0.119 0.940*** −0.406*** 0.272*** 0.181**
(0.094) (0.161) (0.100) (0.130) (0.120) (0.052) (0.065)
Intervention × 5%
weight loss
0.300 0.168 −0.079 −0.378 −0.318 0.125 0.255
(0.231) (0.468) (0.272) (0.369) (0.306) (0.142) (0.193)
Age at baseline (mean-
centered)
−0.017* −0.001 −0.014* 0.011 −0.016** 0.036*** 0.020***
(0.007) (0.012) (0.006) (0.006) (0.006) (0.005) (0.004)
Male dummy 0.184 0.082 −0.450* −0.420* 0.111 −0.541*** −0.122
(0.196) (0.342) (0.177) (0.206) (0.152) (0.114) (0.097)
Faculty dummy −0.364* −0.012 −0.495*** 0.127 0.445*** 0.046 −0.066
(0.177) (0.286) (0.145) (0.159) (0.135) (0.114) (0.089)
Employee unspecified
job dummy
−0.595 −0.149 0.284 −0.108 0.027 0.069 0.107
(0.444) (0.615) (0.336) (0.337) (0.331) (0.176) (0.131)
Bilger et al. Page 10













HRQOL Absenteeism Presenteeism Health Expenditures†
Logit F-logit Logit ZTNB Ordered logit Logit Log-Gamma
GLM
Baseline BMI −0.028* −0.007 0.015 0.012 0.044*** 0.008 0.019***
(0.011) (0.018) (0.009) (0.009) (0.009) (0.008) (0.006)
Co-morbidities −0.566** −0.106 0.352* −0.069 0.181 1.002*** 0.363***
(0.207) (0.298) (0.160) (0.164) (0.157) (0.176) (0.100)
Incentive Study −0.021 −0.020 −0.064 0.203 0.062 0.115 −0.075
(0.142) (0.233) (0.120) (0.131) (0.113) (0.103) (0.078)
Web-based study −0.100 0.004 0.084 −0.412*** 0.122 0.132 −0.058
(0.141) (0.232) (0.117) (0.124) (0.111) (0.097) (0.076)
CDC dummy N/A N/A −0.199 0.329* N/A −0.222* 0.051
(0.122) (0.131) (0.106) (0.082)




N/A N/A N/A N/A N/A 0.131 0.109
(0.130) (0.179)
Constant 1.996*** 1.761* −0.988* −0.964* N/A −1.013** 4.962***
(0.542) (0.891) (0.423) (0.448) (0.375) (0.296)
Cut-off 1 N/A N/A N/A N/A 0.931* N/A N/A
(0.425)
Cut-off 2 N/A N/A N/A N/A 1.788*** N/A N/A
(0.427)
Cut-off 3 N/A N/A N/A N/A 2.905*** N/A N/A
(0.434)








Excluding inpatient expenditures, N/A: Non Applicable.
Bilger et al. Page 11
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